Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma

por De Luca, Fabiola, Allegra, Alessandro, Di Chio, Carla, Previti, Santo, Zappalà, Maria, Ettari, Roberta
Publicado 2023

Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome

por Culletta, Giulia, Tutone, Marco, Ettari, Roberta, Perricone, Ugo, Di Chio, Carla, Almerico, Anna Maria, Zappalà, Maria
Publicado 2023

Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

por Di Chio, Carla, Previti, Santo, Totaro, Noemi, De Luca, Fabiola, Allegra, Alessandro, Schirmeister, Tanja, Zappalà, Maria, Ettari, Roberta
Publicado 2023

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis

por Previti, Santo, Ettari, Roberta, Di Chio, Carla, Ravichandran, Rahul, Bogacz, Marta, Hellmich, Ute A., Schirmeister, Tanja, Cosconati, Sandro, Zappalà, Maria
Publicado 2022

Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

por Di Chio, Carla, Previti, Santo, De Luca, Fabiola, Bogacz, Marta, Zimmer, Collin, Wagner, Annika, Schirmeister, Tanja, Zappalà, Maria, Ettari, Roberta
Publicado 2022

Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells

por Ettari, Roberta, Pallio, Giovanni, Pizzino, Gabriele, Irrera, Natasha, Zappalà, Maria, Maiorana, Santina, Di Chio, Carla, Altavilla, Domenica, Squadrito, Francesco, Bitto, Alessandra
Publicado 2019

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

por Previti, Santo, Ettari, Roberta, Calcaterra, Elsa, Di Chio, Carla, Ravichandran, Rahul, Zimmer, Collin, Hammerschmidt, Stefan, Wagner, Annika, Bogacz, Marta, Cosconati, Sandro, Schirmeister, Tanja, Zappalà, Maria
Publicado 2022